Cargando…
三级淋巴结构在非小细胞肺癌预后及免疫治疗中的研究进展
Lung cancer is the leading cause of cancer death, and non-small cell lung cancer (NSCLC) accounts for 85%. Immunotherapy has significantly improved the clinical prognosis of patients with NSCLC. However, because of the complexity and heterogeneousness of the tumor microenvironment, only a subset of...
Autores principales: | LIU, Ying, XIONG, Lei, CAI, Ruoxue, CHEN, Yue, YE, Jinjun, SHEN, Bo, ZHOU, Guoren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial board of Chinese Journal of Lung Cancer
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10558765/ https://www.ncbi.nlm.nih.gov/pubmed/37752541 http://dx.doi.org/10.3779/j.issn.1009-3419.2023.101.23 |
Ejemplares similares
-
AKT2在非小细胞肺癌中的表达及预后意义
Publicado: (2011) -
HDGF在手术切除非小细胞肺癌中的异常表达及其在预测预后中的意义
Publicado: (2011) -
淋巴细胞/单核细胞比值在血管免疫母细胞性T细胞淋巴瘤患者中的预后价值
Publicado: (2018) -
(18)F-FDG PET/CT代谢参数在非小细胞肺癌预后评估中的应用及进展
Publicado: (2019) -
色谱技术在肝素结构分析中的研究进展
por: OUYANG, Yilan, et al.
Publicado: (2023)